13th Award: Effect of Multikinase Inhibitors on Caspase-Independent Cell Death and DNA Damage in HER2-Overexpressing Breast Cancer Cells

A combination of two drugs, trastuzumab and dasatinib, improve the treatment response by 30% in breast cancers, those in which tumour cells show an overexposure to the HER2 protein. This is the discovery of four scientists from Cancer Research Centre (CIC-IBMCC), part of the University of Salamanca and CSIC, who were awarded the 13th Esteve…

2013

7th edition – Barcelona, June, 14-15 2013

If standing up and speaking in front of an audience is a source of anxiety, the stress is heightened even more when the official language of the conference, meeting or congress is English. On the 14th and 15th of June 2013, the Esteve Foundation organized at the Vall d’Hebron Research Institute (VHIR) the seventh edition…

2013

6th edition – Zaragoza, May, 29-30 2013

If standing up and speaking in front of an audience is a source of anxiety, the stress is heightened even more when the official language of the conference, meeting or congress is English. On the 29th and 30th of May 2013, the Esteve Foundation organized at the Hospital Universitario Miguel Servet (Zaragoza) the sixth edition…

2013

5th edition – Barcelona, May, 10-11 2013

If standing up and speaking in front of an audience is a source of anxiety, the stress is heightened even more when the official language of the conference, meeting or congress is English. On the 10th and 11th of May 2013, the Esteve Foundation organized at the Vall d’Hebron Research Institute (VHIR) the fifth edition…

2013

Receptor heteromers: pharmacological properties and therapeutic applications

Receptor heteromers constitute a new area of research that is reshaping our thinking about biochemistry, cell biology, pharmacology and drug discovery. The concept, in which receptors of the same and different gene families can combine among themselves to generate dimers and possibly higher-order entities with uniquebiochemical and functional characteristics, is becoming widely accepted. The latest…